MEDIFAST Historical Financial Ratios
MED Stock | USD 14.44 0.69 5.02% |
MEDIFAST INC is lately reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.25 will help investors to properly organize and evaluate MEDIFAST INC financial condition quickly.
MEDIFAST |
About MEDIFAST Financial Ratios Analysis
MEDIFAST INCFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate MEDIFAST INC investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on MEDIFAST financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across MEDIFAST INC history.
MEDIFAST INC Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing MEDIFAST INC stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on MEDIFAST INC sales, a figure that is much harder to manipulate than other MEDIFAST INC multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is MEDIFAST INC dividend as a percentage of MEDIFAST INC stock price. MEDIFAST INC dividend yield is a measure of MEDIFAST INC stock productivity, which can be interpreted as interest rate earned on an MEDIFAST INC investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from MEDIFAST INC's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Free Cash Flow Yield is projected to increase slightly based on the last few years of reporting. The current year's Operating Cash Flow Per Share is expected to grow to 2.48, whereas Dividend Yield is forecasted to decline to 0.
2022 | 2023 | 2024 | 2025 (projected) | |
Dividend Yield | 0.0555 | 0.0998 | 0.003713 | 0.003527 |
Price To Sales Ratio | 0.81 | 0.68 | 0.32 | 0.3 |
MEDIFAST INC fundamentals Correlations
Click cells to compare fundamentals
MEDIFAST INC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MEDIFAST INC fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 2.47 | 1.61 | 0.81 | 0.68 | 0.32 | 0.3 | |
Dividend Yield | 0.023 | 0.026 | 0.0555 | 0.0998 | 0.003713 | 0.003527 | |
Ptb Ratio | 14.7 | 12.11 | 8.33 | 3.63 | 0.92 | 0.87 | |
Book Value Per Share | 13.36 | 17.3 | 13.85 | 18.51 | 19.22 | 20.18 | |
Free Cash Flow Yield | 0.0603 | 0.0246 | 0.14 | 0.19 | 0.0884 | 0.0928 | |
Operating Cash Flow Per Share | 12.34 | 8.08 | 17.38 | 13.57 | 2.24 | 2.48 | |
Stock Based Compensation To Revenue | 0.00727 | 0.006489 | 0.006914 | 0.007638 | 0.0122 | 0.0116 | |
Capex To Depreciation | 0.81 | 5.02 | 1.52 | 0.49 | 0.63 | 0.59 | |
Pb Ratio | 14.7 | 12.11 | 8.33 | 3.63 | 0.92 | 0.87 | |
Ev To Sales | 1.72 | 2.31 | 1.56 | 0.77 | 0.2 | 0.19 | |
Free Cash Flow Per Share | 11.83 | 5.15 | 15.89 | 12.97 | 1.56 | 2.04 | |
Roic | 0.6 | 0.7 | 0.77 | 0.43 | 0.007024 | 0.006673 | |
Inventory Turnover | 4.44 | 2.21 | 3.85 | 5.43 | 3.72 | 2.66 | |
Net Income Per Share | 8.74 | 14.01 | 12.82 | 9.13 | 0.19 | 0.18 | |
Days Of Inventory On Hand | 82.22 | 164.91 | 94.69 | 67.27 | 98.1 | 93.19 | |
Payables Turnover | 6.57 | 5.62 | 8.63 | 7.56 | 6.85 | 4.94 | |
Research And Ddevelopement To Revenue | 0.002995 | 0.002883 | 0.002815 | 0.004291 | 0.004934 | 0.004903 | |
Capex To Revenue | 0.006297 | 0.0224 | 0.0104 | 0.006047 | 0.0124 | 0.0118 | |
Cash Per Share | 14.82 | 9.36 | 7.83 | 13.79 | 14.85 | 15.6 | |
Pocfratio | 15.92 | 25.93 | 6.64 | 4.95 | 7.87 | 8.29 | |
Payout Ratio | 0.52 | 0.39 | 0.5 | 0.73 | 0.34 | 0.21 | |
Capex To Operating Cash Flow | 0.0405 | 0.36 | 0.0857 | 0.0439 | 0.3 | 0.32 | |
Pfcf Ratio | 16.59 | 40.63 | 7.26 | 5.18 | 11.31 | 11.88 | |
Days Payables Outstanding | 55.58 | 64.94 | 42.32 | 48.3 | 53.3 | 70.82 | |
Income Quality | 1.41 | 0.58 | 1.36 | 1.49 | 11.71 | 12.29 | |
Roe | 0.65 | 0.81 | 0.93 | 0.49 | 0.009952 | 0.009454 | |
Ev To Operating Cash Flow | 14.87 | 25.17 | 6.32 | 4.46 | 4.81 | 6.34 | |
Pe Ratio | 22.47 | 14.94 | 8.99 | 7.36 | 92.1 | 87.5 | |
Return On Tangible Assets | 0.37 | 0.41 | 0.45 | 0.32 | 0.007357 | 0.006989 | |
Ev To Free Cash Flow | 15.49 | 39.44 | 6.91 | 4.67 | 6.92 | 7.27 | |
Earnings Yield | 0.0445 | 0.0669 | 0.11 | 0.14 | 0.0109 | 0.0114 | |
Net Debt To E B I T D A | (1.14) | (0.32) | (0.31) | (0.52) | (25.99) | (24.69) | |
Current Ratio | 2.1 | 1.81 | 1.58 | 2.43 | 3.34 | 2.33 | |
Tangible Book Value Per Share | 13.36 | 17.3 | 13.85 | 18.51 | 19.22 | 20.18 | |
Graham Number | 51.25 | 73.85 | 63.22 | 61.68 | 9.1 | 14.58 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth (0.38) | Return On Assets |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.